Risk prediction in heart failure using invasive hemodynamics.

IF 3.7 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Clinical Research in Cardiology Pub Date : 2025-10-01 Epub Date: 2025-07-10 DOI:10.1007/s00392-025-02690-9
Martin Joachim Kraus, Aleksandre Veshapeli, Christoph Reich, Hauke Hund, Sonja Hamed, Philip W Raake, Michael M Kreusser, Norbert Frey, Lorenz Lehmann
{"title":"Risk prediction in heart failure using invasive hemodynamics.","authors":"Martin Joachim Kraus, Aleksandre Veshapeli, Christoph Reich, Hauke Hund, Sonja Hamed, Philip W Raake, Michael M Kreusser, Norbert Frey, Lorenz Lehmann","doi":"10.1007/s00392-025-02690-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Risk stratification in patients with heart failure patients is crucial. The prognostic value of invasive hemodynamic parameters measured by right heart catheterization compared to established risk scores remains unknown.</p><p><strong>Methods and results: </strong>This retrospective analysis included 883 patients. The combined endpoint was all-cause mortality, heart transplantation or left ventricular assist device implantation. A Cox proportional hazards model assessed the impact of invasive parameters, cardiac biomarkers, and patient characteristics, comparing them with the Seattle Heart Failure Model (SHFM) and the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) Score. A new score was created including mean pulmonary arterial (PA) pressure, mean right atrial pressure, mean pulmonary artery wedge pressure (PAWP), age, N-terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitivity troponin T (hsTnT), mixed venous oxygen saturation (SVO2), creatinine, and presence of ischemic cardiomyopathy. Mean, diastolic, and systolic PA pressure, mean right atrial pressure, mean PAWP, SVO2 and cardiac index were significant predictors for the primary endpoint reached by 467/883 (53%) patients, in a multiple Cox proportional hazards model (p < 0.001). The predictive value was diminished in a subgroup of patients with ischemic cardiomyopathy. We used invasive parameters, age, NT-proBNP, hsTnT<sub>,</sub> creatinine presence of ischemic cardiomyopathy and sex to develop a new model for risk stratification. This new score showed better performance compared to the SHFM and MAGGIC score in predicting the primary endpoint at 6, 12 and 24 months (area under the curve 0.76, 0.78 and 0.77 vs 0.71/0.69, 0.70/0.68 and 0.70/0.70).</p><p><strong>Conclusion: </strong>Invasive hemodynamics provides valuable measurements for predicting outcome in heart failure with reduced ejection fraction and show better performance than established risk models when combined with cardiac biomarkers and other clinical variables in this particular cohort.</p>","PeriodicalId":10474,"journal":{"name":"Clinical Research in Cardiology","volume":" ","pages":"1388-1399"},"PeriodicalIF":3.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460544/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research in Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00392-025-02690-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Risk stratification in patients with heart failure patients is crucial. The prognostic value of invasive hemodynamic parameters measured by right heart catheterization compared to established risk scores remains unknown.

Methods and results: This retrospective analysis included 883 patients. The combined endpoint was all-cause mortality, heart transplantation or left ventricular assist device implantation. A Cox proportional hazards model assessed the impact of invasive parameters, cardiac biomarkers, and patient characteristics, comparing them with the Seattle Heart Failure Model (SHFM) and the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) Score. A new score was created including mean pulmonary arterial (PA) pressure, mean right atrial pressure, mean pulmonary artery wedge pressure (PAWP), age, N-terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitivity troponin T (hsTnT), mixed venous oxygen saturation (SVO2), creatinine, and presence of ischemic cardiomyopathy. Mean, diastolic, and systolic PA pressure, mean right atrial pressure, mean PAWP, SVO2 and cardiac index were significant predictors for the primary endpoint reached by 467/883 (53%) patients, in a multiple Cox proportional hazards model (p < 0.001). The predictive value was diminished in a subgroup of patients with ischemic cardiomyopathy. We used invasive parameters, age, NT-proBNP, hsTnT, creatinine presence of ischemic cardiomyopathy and sex to develop a new model for risk stratification. This new score showed better performance compared to the SHFM and MAGGIC score in predicting the primary endpoint at 6, 12 and 24 months (area under the curve 0.76, 0.78 and 0.77 vs 0.71/0.69, 0.70/0.68 and 0.70/0.70).

Conclusion: Invasive hemodynamics provides valuable measurements for predicting outcome in heart failure with reduced ejection fraction and show better performance than established risk models when combined with cardiac biomarkers and other clinical variables in this particular cohort.

利用有创性血流动力学预测心力衰竭的风险。
目的:心衰患者的风险分层是至关重要的。通过右心导管测量的侵入性血流动力学参数与已建立的风险评分相比的预后价值仍然未知。方法与结果:回顾性分析883例患者。联合终点是全因死亡率、心脏移植或左心室辅助装置植入。Cox比例风险模型评估了侵入性参数、心脏生物标志物和患者特征的影响,并将其与西雅图心力衰竭模型(SHFM)和慢性心力衰竭(MAGGIC)评分荟萃分析全球组进行比较。新评分包括平均肺动脉压(PA)、平均右心房压、平均肺动脉压(PAWP)、年龄、n端脑利钠肽前体(NT-proBNP)、高敏肌钙蛋白T (hsTnT)、混合静脉氧饱和度(SVO2)、肌酐和缺血性心肌病的存在。在多Cox比例风险模型(p、肌酐是否存在缺血性心肌病和性别)中,平均、舒张压和收缩压、平均右心房压、平均paap、SVO2和心脏指数是467/883(53%)患者达到的主要终点的重要预测因素,以建立新的风险分层模型。与SHFM和MAGGIC评分相比,该新评分在预测6、12和24个月的主要终点方面表现更好(曲线下面积0.76、0.78和0.77 vs 0.71/0.69、0.70/0.68和0.70/0.70)。结论:在该特定队列中,有创血流动力学为预测射血分数降低的心力衰竭结局提供了有价值的测量方法,并且在结合心脏生物标志物和其他临床变量时,比建立的风险模型表现更好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Research in Cardiology
Clinical Research in Cardiology 医学-心血管系统
CiteScore
11.40
自引率
4.00%
发文量
140
审稿时长
4-8 weeks
期刊介绍: Clinical Research in Cardiology is an international journal for clinical cardiovascular research. It provides a forum for original and review articles as well as critical perspective articles. Articles are only accepted if they meet stringent scientific standards and have undergone peer review. The journal regularly receives articles from the field of clinical cardiology, angiology, as well as heart and vascular surgery. As the official journal of the German Cardiac Society, it gives a current and competent survey on the diagnosis and therapy of heart and vascular diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信